Ontology highlight
ABSTRACT: Background
Three large cardiovascular outcome trials have investigated the safety of sodium glucose cotransporter 2 (SGLT2) inhibitors.Objective
To analyze the nationwide dispensing of SGLT2 inhibitors before and after the publication of these trials.Methods
A cross-sectional study was conducted of monthly prescription dispensing of SGLT2 inhibitors from May 23, 2014, to April 30, 2019, using nationwide data for Canada. An autoregressive integrated moving average (ARIMA) model was fitted to the monthly number of tablets dispensed for each SGLT2 inhibitor; the model included a ramp intervention function at the publication dates of interest to estimate the impact on SGLT2 inhibitor dispensing patterns.Results
The rate of canagliflozin and dapagliflozin dispens
SUBMITTER: Fralick M
PROVIDER: S-EPMC8956473 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature